High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device

ConclusionAF is common in patients with HCM who need a CRM device. More than 50% of these patients develop de novo AF that was predominantly subclinical in our cohort.This article is protected by copyright. All rights reserved

Source: Journal of Cardiovascular Electrophysiology - April 5, 2016 Category: Cardiology Authors: IRIS WILKE, KATRIN WITZEL, JULIA MÜNCH, SIMON PECHA, STEPHAN BLANKENBERG, HERMANN REICHENSPURNER, STEPHAN WILLEMS, MONICA PATTEN, ALI AYDIN Tags: Original ‐ Clinical Source Type: research